Hello and welcome to IBA’s Full Year 2024 Results Conference Call. I am Thomas Pevenage, Head of Investor Relations of IBA. As usual, you will find this presentation on the Investor Relations page of ...
As the European markets experience a mix of modest gains and losses, with indices like Germany's DAX and Italy's FTSE MIB ...
IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and leading provider of proton therapy solutions for the treatment of cancer, today announced that it ...
Centre for Ion Beam applications at NUS designated as IAEA’s first collaborating centre in Singapore
The Centre for Ion Beam Applications (CIBA), a multidisciplinary research centre at the National University of Singapore (NUS), has recently been designated as an International Atomic Energy Agency ...
Belgian radiotherapy equipment manufacturer Ion Beam Applications S.A. (IBA) has acquired German PhantomX GmbH. This is reported in the IBA press release. The deal is aimed at expanding IBA's ...
Kepler Capital analyst Matthias Maenhaut maintained a Sell rating on Ion Beam Applications SA IBA (0GZK – Research Report) on September 12 and set a price target of €11.75. The company’s shares closed ...
Ion Beam Applications S.A. Annual stock financials by MarketWatch. View the latest IBAB financial statements, income statements and financial ratios.
The average one-year price target for Ion Beam Applications (EBR:IBAB) has been revised to 24.53 / share. This is an increase of 9.15% from the prior estimate of 22.47 dated July 5, 2023. The price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback